Explore/

Minimally Invasive Surgery

Minimally Invasive Surgery

2.36k followers19 symbols Watchlist by Motif Investing

Global adoption of minimally invasive procedures could spark new growth. The global minimally invasive surgery market is forecast to reach $35.5 billion by the end of 2016 with compound annual growth rate ("CAGR") of 8.2%.

19 Symbols

To view complete list, get the Yahoo Finance App

Get the Yahoo Finance app

  • Free real-time data
  • News and price alerts
  • Add and edit holdings
  • Track performance
  • Create multiple watchlists
  • 5 Top Healthcare Stocks to Buy in 2019
    Motley Fool2 days ago

    5 Top Healthcare Stocks to Buy in 2019

    Healthcare is hot, and these top healthcare stocks could be among the hottest of them all this year.

  • Is Intuitive Surgical, Inc. (NASDAQ:ISRG) Worth US$528 Based On Its Intrinsic Value?
    Simply Wall St.2 days ago

    Is Intuitive Surgical, Inc. (NASDAQ:ISRG) Worth US$528 Based On Its Intrinsic Value?

    How far off is Intuitive Surgical, Inc. (NASDAQ:ISRG) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by projecting its future cash flows and then discounting...

  • Thomson Reuters StreetEvents2 days ago

    Edited Transcript of ISRG earnings conference call or presentation 18-Apr-19 8:30pm GMT

    Q1 2019 Intuitive Surgical Inc Earnings Call

  • Intuitive Surgical Inc (ISRG) Q1 2019 Earnings Call Transcript
    Motley Fool2 days ago

    Intuitive Surgical Inc (ISRG) Q1 2019 Earnings Call Transcript

    ISRG earnings call for the period ending March 31, 2019.

  • CNBC2 days ago

    Stocks making the biggest moves after hours: Intuitive Surgical, Pinterest and more

    See which stocks are posting big moves after the bell on April 18.

  • Robotic Surgery Giant Intuitive Surgical Crashes On First-Quarter Miss
    Investor's Business Daily2 days ago

    Robotic Surgery Giant Intuitive Surgical Crashes On First-Quarter Miss

    Intuitive Surgical stock crashed late Thursday after the surgical robotics firm's quarterly sales missed estimates. Intuitive Surgical earnings also lagged during the period.

  • InvestorPlace2 days ago

    Intuitive Surgical Earnings: ISRG Stock Sinks on Q1 Profit Miss

    Intuitive Surgical (NASDAQ:ISRG) unveiled its latest quarterly earnings results after the bell today, amassing mostly disappointing results as both earnings and revenue were below what Wall Street called for in its consensus estimate, playing a role in ISRG stock sinking late in the day.The Sunnyvale, Calif.-based maker of robotic surgical products designed to improve patient outcomes said that for its first quarter of its fiscal 2019, it amassed net income of $306.5 million, or $2.56 per share. This figure marked a 6.6% gain over the profit it tallied during the same period in its fiscal 2018, which came in at $287.6 million, or $2.44 per share.On an adjusted basis, Intuitive Surgical said it brought in earnings of $2.61 per share, which was weaker than the Wall Street consensus estimate. Analysts who were surveyed by FactSet reached an average adjusted earnings guidance of $2.70 per share for the company's first quarter.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe medical robotics business added that it raked in sales of $973.7 million, marking a 14.9% improvement over the $847.5 million in revenue it had during its first quarter of 2018. Wall Street was calling for Intuitive Surgical to compile sales of $975.3 million for the period, also according to data compiled from a survey conducted by FactSet.ISRG stock had been increasing about 0.6% during regular trading hours as the company geared up to report its results for its latest quarter. However, an earnings and sales miss caused Intuitive Surgical's shares to decline roughly 6.3% after the bell on Thursday. More From InvestorPlace * 5 Dividend Stocks Perfect for Retirees * 10 S&P 500 Stocks to Buy Off Their Lows * 7 Stocks to Buy for Spring Season Growth Compare Brokers The post Intuitive Surgical Earnings: ISRG Stock Sinks on Q1 Profit Miss appeared first on InvestorPlace.

  • MarketWatch2 days ago

    Intuitive Surgical stock falls after earnings miss

    Intuitive Surgical Inc. shares dropped in the extended session Thursday after the surgical robot maker's quarterly results fell short of Wall Street estimates. Intuitive Surgical shares fell 7.3% after hours, following a 0.6% gain to close the regular session at $528.06. The company reported first-quarter net income of $306.5 million, or $2.56 a share, compared with $287.6 million, or $2.44 a share, in the year-ago period. Adjusted earnings were $2.61 a share. Revenue rose to $973.7 million from $847.5 million in the year-ago quarter. Analysts surveyed by FactSet had forecast earnings of $2.70 a share on revenue of $975.3 million.

  • 7 Companies That Are Closing the CEO-Worker Wage Gap
    InvestorPlace3 days ago

    7 Companies That Are Closing the CEO-Worker Wage Gap

    A 2018 survey of CEO pay in 22 countries around the world including the U.S. found that the average CEO was paid $3.55 million annually.Here in Canada, where I live, the average CEO was paid a little more than $7 million. In the UK, it was almost a million higher than Canada.How about the U.S.?InvestorPlace - Stock Market News, Stock Advice & Trading TipsWell, it was the number one country for CEO pay at $14.25 million -- or more than four times the global average. Are U.S. CEOs worth that much -- or that much more than CEOs in other countries? Not by a long shot. But that doesn't stop some professorial types from singing their praises."The efforts of America's highest-earning 1% have been one of the more dynamic elements of the global economy. It's not popular to say, but one reason their pay has gone up so much is that CEOs really have upped their game relative to many other workers in the U.S. economy," stated George Mason University Economics professor Tyler Cowen in his recent book Big Business: A Love Letter to an American Anti-Hero. CEOs might have a more complicated job than they had 20 years ago, but that doesn't justify pay that is 361 times the average U.S. rank-and-file worker. U.S. Congressman Keith Ellison released a report in 2018 that suggested a median employee at Mattel (NYSE:MAT) would have to work at the company for 495 years to earn as much as a CEO's annual pay. Ridiculous. Investors need only to consider one fact. "Since 2008, the 100 companies with the lowest CEO compensation within the S&P 500 index have outperformed the 100 with the highest compensation every year except 2013," Bloomberg reported in March of this year. "The annualized return from 2008 to 2018 was 17.2 percent compared with 8.4 percent."It is clear that investing in companies who are doing a good job cutting the gap between the CEO's pay and the average employee is key to your portfolio's future success. * The Jobs Report Isn't an Effective Metric for the U.S. Economy Here are seven stocks to buy in that vein. Intuitive Surgical (ISRG)Source: Jon Fingas via Flickr (Modified)CEO Pay: $5.1 millionPay Ratio: 32:1The median worker's pay at Intuitive Surgical (NASDAQ:ISRG) is $157,491, the 22nd highest amount of compensation in the S&P 500. It kind of makes sense. Do you really want a bunch of low-paid workers manufacturing the company's da Vinci surgical robotic systems? One wrong move and your hernia repair becomes a one-way ticket to the morgue. I'm facetious, but I think you get my meaning. By having well-paid employees, not only are they likely to be happier; they're probably more productive especially when they realize that the CEO makes just 32 times their pay, about one-tenth the U.S. average. Intuitive Surgical has come a long way from 1999 when it launched the first da Vinci system. At the end of 2018, it had almost 5,000 systems installed; 64% of them in the U.S. with Europe and Asia its next biggest markets, but with plenty of room to grow. The global surgical robotics market is expected to grow by almost 14% annually over the next seven years to $17 billion. ISRG currently has a 17% market share. If it grows that market share to 25% by 2025, it translates into an additional $1.4 billion in revenue. As people age, minimally invasive surgery will become even more critical than it already is. As secular trends go, ISRG is one of the best bets you can make. American Water Works (AWK)Source: Shutterstock CEO Pay: $4.4 millionPay Ratio: 53:1American Water Works (NYSE:AWK) CEO Susan Story is the only woman on this list so if ESG issues are of interest to you; AWK is an excellent stock to consider. As for its business, that's also good. AWK was recently named one of Barron's 100 Most Sustainable U.S. Companies. Also, Bloomberg included AWK on its list of 230 companies for the 2019 Bloomberg Gender-Equality Index (GEI), a group selected for their dedication advancing the cause of women. That's a big deal when you consider that providing equal pay for U.S. women would add $512 billion to the economy on an annual basis. Here's another reason to like the water utility. AWK stock hasn't had a single year with a negative total return delivering a 10-year annualized total return of 20.6%, which goes entirely against the theory that utilities are dull and poor performers over the long haul. * 5 Dividend Stocks Perfect for Retirees Providing water services to more than 14 million people in 46 states, AWK is a stock whose business will never go the way of the Dodo bird. Fastenal (FAST)Source: Shutterstock CEO Pay: $2.0 million Pay Ratio: 58:1If you've owned Fastenal (NASDAQ:FAST) for the past five years, your patience is finally being rewarded after spending four years rangebound between $40-$50. Up 32% year to date through April 15, FAST stock looks like its gallop to $100 is underway. Consider that the supplier of industrial and construction supplies grew revenues and operating profits over the past five years by 49% and 40% to $5.0 billion and $1.0 billion respectively. And for that, its stock went sideways. In the company's Q1 2019 earnings, Fastenal grew the top and bottom lines by double digits. Revenues were up 12.2% on a like-for-like basis, and net earnings rose 11.9% to $0.68 a share. Helping move the needle is its industrial vending machine program. In the first quarter, it signed 5,603, bringing the total number to 83,410, an increase of 13.4% over Q1 2018. Sales at those machines grew in the high teens in the first quarter. And you thought vending machines were a thing of the past. Fastenal is all about customer service. It's got the growth to prove it. Amazon (AMZN)Source: Shutterstock CEO Pay: $1.7 millionPay Ratio: 59:1Say what you will about Amazon (NASDAQ:AMZN) CEO and founder Jeff Bezos, but you can't deny his company's success. A $10,000 investment ten years ago is worth almost $247,000 today. Bezos might be amoral or immoral in your opinion but his ability to deliver what the world's craving is astonishing. Everything Amazon does is to please the customer. In Bezos' annual letter to shareholders, he mentions the word customer on 49 occasions. "Much of what we build at AWS is based on listening to customers. It's critical to ask customers what they want, listen carefully to their answers, and figure out a plan to provide it thoughtfully and quickly (speed matters in business!). No business could thrive without that kind of customer obsession. But it's also not enough. The biggest needle movers will be things that customers don't know to ask for," the CEO wrote. * 7 Stocks to Buy for Spring Season Growth How many CEOs do you know that think like this? I can count the number on two hands. He might be an a**hole in the minds of many, but he's a brilliant one, cut from the same cloth as Elon Musk. Garmin (GRMN)Source: slgckgc via Flickr (modified)CEO Pay: $2.4 millionPay Ratio: 76:1The cream always rises to the top. Garmin (NASDAQ:GRMN) is one of those companies that seems to fly under the radar despite being a reasonably large company. If you own Fitbit (NASDAQ:FIT) stock, however, you're likely more than a little aware of Garmin. In the most recent quarter, Garmin delivered boffo earnings. Since announcing Q4 2018 results February 20, GRMN stock is up 24%. A key highlight from earnings was its guidance for 2019. Analysts were expecting earnings of $3.52 a share on $3.43 billion in revenue. Garmin CEO Cliff Pemble's outlook is for $3.70 a share on the bottom line and $3.50 billion on the top line. "2018 was another remarkable year of revenue and operating income growth driven by strong performance in our aviation, marine, outdoor and fitness segments," Pemble said in its news release. "Entering 2019, we see many opportunities ahead and believe that we are well positioned to seize these opportunities with a strong lineup of products across all of our segments."Hopefully, you're beginning to see a trend. Companies that keep the pay ratio low tend to deliver strong long-term results. Since Pemble became CEO in January 2013, GRMN stock has generated a 19.7% annualized total return for shareholders, 440 basis points greater than the SPDR S&P 500 ETF (NYSEARCA:SPY). Simon Property (SPG)Source: m01229 via Flickr (Modified)CEO Pay: $4.8 million Pay Ratio: 88:1A lot of investors might have a problem owning shopping malls. I certainly wouldn't. But they've got to be good. They can't be Class C malls with no-name retailers filling the place. That's a recipe for disaster. Zacks recently wondered if Simon Property's (NYSE:SPG) efforts were enough to battle the retail blues. Are we seriously still having that discussion in 2019. Well, it turns out there are a lot of crappy retailers still operating including Sears. "The deepening of the relationship with existing tenants, and the launch of its online retail platform, weaved with an omni-channel strategy, will likely be accretive to Simon Property's long-term growth," wrote Zack's equity research team April 8."In fact, the company is investing billions and actively restructuring its portfolio, aiming at premium acquisitions and transformative redevelopments. The transformational plans include the addition of hotels, restaurants, residences and luxury stores."The fact is, very few retail mall owners have the vision of the Simon family. They've been doing this a long time. They're more than capable of rolling with the punches. * 10 S&P 500 Stocks to Weather the Earnings Storm Good brick-and-mortar retail isn't disappearing. Just the crappy kind is. Know the difference. O'Reilly Automotive (ORLY)Source: JJBers via Flickr (modified)CEO Pay: $2.9 millionPay Ratio: 141:1O'Reilly Automotive (NASDAQ:ORLY) makes it on to the list despite hitting a 26-year high of $398.41 in early April and carrying on past $400 in the days that followed. Up 19% year to date through April 15, ORLY's only had one year of negative returns since 2009. As a result, you're looking at a 10-year annualized total return of 27.3%, almost double the S&P 500. In 2018, the retailer of aftermarket auto parts had same-store sales growth of 3.8%, at the top of its estimate for the year, the company's 26th year with an increase. In 2019, it expects same-store sales growth of 3%-5%. This past year it opened 200 net new stores in 36 states. It plans to open as many as 210 in 2019. It now has 5,219 stores across the U.S. On the bottom line, O'Reilly increased its EPS by 27% over 2017 to $16.10, the 10th consecutive year with a 15% increase in earnings. In 2019, it expects EPS of at least $17.37. Given its track record, you should expect more than that. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 Dividend Stocks Perfect for Retirees * 7 Reasons the Stock Market Rally Isn't Over Yet * 10 S&P 500 Stocks to Weather the Earnings Storm Compare Brokers The post 7 Companies That Are Closing the CEO-Worker Wage Gap appeared first on InvestorPlace.

  • A Diabetes Treatment Revolution Could Bolster These Medtech Firms
    Investor's Business Daily3 days ago

    A Diabetes Treatment Revolution Could Bolster These Medtech Firms

    Medical device companies like Abbott, Medtronic and Tandem Diabetes are jockeying for a piece of the diabetes treatment market, which could be worth north of $2 trillion by 2030.

  • Intuitive Surgical Stock Is Down but Not Out
    InvestorPlace3 days ago

    Intuitive Surgical Stock Is Down but Not Out

    For the last few weeks, healthcare stocks have been hit hard. This is not from any fundamental fault of their own, but rather from political rhetoric. Both Republicans and Democrats alike want to punish them as we near another round of elections. But therein lies the opportunity.Source: Jon Fingas via Flickr (Modified)The politicians can inflict harm on the stock price of Intuitive Surgical (NASDAQ:ISRG), for example, but eventually, the Profit and Loss statement will win over the fear mongering. After all this is a company that has been delivering phenomenal results for years and will continue to do so for more to come.But for now, the stock price is falling, so I consider this trade tactical from the sense that I'd be catching a falling knife. Usually I don't like to be the hero, but in this case, I am confident in Intuitive Surgical's long-term prospects, so I don't mind turning this trade into an investment.InvestorPlace - Stock Market News, Stock Advice & Trading TipsTherefore, I can buy the shares outright here going into earnings. If they sell it off on Monday, then I would add to my stake once they hit the right levels to do that. ISRG Stock by the NumbersFundamentally, Intuitive Surgical stock is not cheap. It sells at a 56 trailing price-to-earnings ratio and 16 times sales. But it is a growth stock, so for now I don't worry too much about the margin. When the company matures and starts to stagnate, then I'll judge it more on profitability. * 5 Dividend Stocks Perfect for Retirees The stock recently had a full correction (as Wall Street defines the term) as it fell more than 10% in mere days. Luckily, it did so from a fresh all-time high. In February, ISRG broke out into a bullish pattern, and true to its form, the stock filled the entire target. I've seen this happen in this stock many times before, so this is a chart that respects technical formations.To that point, ISRG broke down from the very sharp rising wedge ahead of the earnings. This resulted in taking out a lot of recent froth from the recent rally. This was an inevitable scenario, but one that doesn't change the bullish thesis. It is merely short-term price action where traders booked fast profits going into a binary event.So in theory I can go long the shares ahead of tonight's earnings report. But doing so would leave me vulnerable to a short term dip from the coin flip event. So it's best to take the position in tranches -- one today and the next I can add to it next week. This would leave me room to average my entry cost lower, so I can hold the stock with better conviction.The options markets provide other ways to trade the stock. One is to limit the out-of-pocket expense and replace the stock purchase with that of June calls or call spreads. But unlike the stock, the risk there is that time becomes my enemy. To profit with calls, I would need the move to happen soon, else I risk losing money even if the stock doesn't fall.That is why I prefer to sell downside risk into what others fear. Wednesday, ISRG stock fell 6.5% so I could sell the April 26 $455 put to collect $2 per share. The money goes into my account now, and if ISRG stays above that level then I created income out of thin air. Otherwise, I would break even at $453 per share.For a longer-term trade, I would sell the July $400 put, which would create the opportunity to profit $4 per contract while leaving me a 23% buffer from the current price. In return, I commit to buying shares at $400 if the price falls through that level between now and July. In that case, I don't start losing money until $396 per share.So this drop in ISRG stock does not change its long-term outlook. This is normal price action that is part of any breakout. The bulls have to retest the necklines from which they broke out to make sure they are solid enough to take the next leg higher.After the recent correction ISRG lags the S&P 500 for 2019, but year-to-date it is still a super star stock. In the past 12 months, ISRG stock is up almost three times more than the S&P. Moreover, it corrected because of the negative sentiment against all healthcare stocks.Nicolas Chahine is the managing director of SellSpreads.com. As of this writing, he did not hold a position in any of the aforementioned securities. You can follow him as @racernic on Twitter and Stocktwits. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 Dividend Stocks Perfect for Retirees * 7 Reasons the Stock Market Rally Isn't Over Yet * 10 S&P 500 Stocks to Weather the Earnings Storm Compare Brokers The post Intuitive Surgical Stock Is Down but Not Out appeared first on InvestorPlace.

  • Thomson Reuters StreetEvents3 days ago

    Edited Transcript of MDT earnings conference call or presentation 19-Feb-19 1:00pm GMT

    Q3 2019 Medtronic PLC Earnings Call

  • Investing.com3 days ago

    Intuitive Surgical Earnings, Revenue Miss in Q1

    Investing.com - Intuitive Surgical (NASDAQ:ISRG) reported first quarter earnings that missed analysts' expectations on Thursday and revenue that fell short of forecasts.

  • Can Boston Scientific's (BSX) Steady Growth Aid Q1 Earnings?
    Zacks3 days ago

    Can Boston Scientific's (BSX) Steady Growth Aid Q1 Earnings?

    We are optimistic about Boston Scientific's (BSX) IC business that will help maintain its impressive global growth trend in Q1 owing to an innovative portfolio and strong commercial teams.

  • Benzinga3 days ago

    The Daily Biotech Pulse: Hookipa To Debut, Mustang Bio Skyrockets, AngioDynamics Sheds Portfolio

    Here's a roundup of top developments in the biotech space over the last 24 hours: No biotech stocks hit 52-week highs on Thursday. Down In The Dumps (Biotech stocks hitting 52-week lows on April 17) ABIOMED, ...

  • Investing.com3 days ago

    Top 5 Things to Know in The Market on Thursday

    Investing.com -- Here are the top 5 things you need to know in financial markets on Thursday, April 18.

  • AngioDynamics will sell Namic business for $167.5 million
    American City Business Journals3 days ago

    AngioDynamics will sell Namic business for $167.5 million

    The sale is expected to close by the end of May. Once that occurs, 330 to 350 AngioDynamics employees are expected to join Medline Industries Inc., a privately-held company headquartered near Chicago.

  • How Financially Strong Is Hologic, Inc. (NASDAQ:HOLX)?
    Simply Wall St.4 days ago

    How Financially Strong Is Hologic, Inc. (NASDAQ:HOLX)?

    Hologic, Inc. (NASDAQ:HOLX), a large-cap worth US$13b, comes to mind for investors seeking a strong and reliable stock investment. One reason being its ‘too big to fail’ aura which gives it the appearance of a strong and stable inv...

  • Why AngioDynamics, Inc.’s (NASDAQ:ANGO) Return On Capital Employed Might Be A Concern
    Simply Wall St.4 days ago

    Why AngioDynamics, Inc.’s (NASDAQ:ANGO) Return On Capital Employed Might Be A Concern

    Today we'll evaluate AngioDynamics, Inc. (NASDAQ:ANGO) to determine whether it could have potential as an investment idea. Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how e...

  • Conmed (CNMD) Reports Next Week: What You Should Expect
    Zacks4 days ago

    Conmed (CNMD) Reports Next Week: What You Should Expect

    Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    Zacks4 days ago

    Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Double Top Spells Trouble for 3 Health Care Stocks
    Investopedia4 days ago

    Double Top Spells Trouble for 3 Health Care Stocks

    Health care stocks have fallen out of favor due to sector rotation and political pressure. Explore three trading ideas to benefit from falling prices.

  • Benzinga4 days ago

    The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 16) Eidos Therapeutics Inc (NASDAQ: EIDX )(reported fourth ...

  • Reuters4 days ago

    Boston Scientific sees $25 mln hit to 2019 revenue from mesh withdrawal

    Boston Scientific Corp on Wednesday said it expects a setback of about $25 million to its full-year revenue due to the U.S. Food and Drugs Administration's order to halt sales of its transvaginal surgical mesh products. The FDA on Tuesday ordered Boston Scientific and Danish firm Coloplast A/S to immediately pull their mesh implants from the market as the companies did not demonstrate a reasonable assurance of safety and effectiveness of the devices. The company said it will continue to assess any potential additional impact to the business due to the FDA's decision that applies to two of Boston Scientific's products.

  • Intuitive Surgical shares fall on earnings miss
    CNBC Videos2 days ago

    Intuitive Surgical shares fall on earnings miss

    CNBC's Kate Rogers reports on Intuitive Surgical's quarterly earnings numbers.